Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 26, 2016 - Issue 1
Submit an article Journal homepage
154
Views
2
CrossRef citations to date
0
Altmetric
Patent Evaluations

RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation

Haifan WuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA94158, USA;Department of Chemistry, University of South Florida, Tampa, FL33620, USA
,
Jinzhi JiangCollege of Chemistry and Chemical Engineering, Central South University, Changsha, HN410083, P. R. China
,
Hai XuCollege of Chemistry and Chemical Engineering, Central South University, Changsha, HN410083, P. R. China
,
Qi LiDepartment of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai201203, China
&
Jianfeng CaiDepartment of Chemistry, University of South Florida, Tampa, FL33620, USACorrespondence[email protected]
Pages 131-137 | Published online: 11 Nov 2015

Bibliography

  • Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
  • Acker T, Plate KH. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J Mol Med. 2002;80(9):562–575.
  • Pedchenko V, Zent R, Hudson BG. Alpha(v)beta(3) and alpha(v)beta(5) integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha 3 chain of type IV collagen - implication for the mechanism of endothelial cell adhesion. J Biol Chem. 2004;279(4):2772–2780.

•• Key review of RGD-based cancer therapy and diagnosis.

  • Danhier F, Le Breton A, Preat V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharmaceut. 2012;9(11):2961–2973.

• Paper about the roles of integrin αvβ3 on tumor growth

  • Felding-Habermann B, Fransvea E, O’Toole TE, et al. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastas. 2002;19(5):427–436.
  • Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alpha(v)beta(3) targeted radiotracers for tumor imaging. Mol Pharmaceut. 2006;3(5):472–487.
  • Kumar CC. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets. 2003;4(2):123–131.
  • Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 1984;309(5963):30–33.
  • Dechantsreiter MA, Planker E, Matha B, et al. N-methylated cyclic RGD peptides as highly active and selective alpha(v)beta(3) integrin antagonists. J Med Chem. 1999;42(16):3033–3040.
  • Goodman SL, Holzemann G, Sulyok GAG, et al. Nanomolar small molecule inhibitors for alpha v beta 6, alpha v beta 5, and alpha v beta 3 integrins. J Med Chem. 2002;45(5):1045–1051.
  • Wang H, Chen K, Cai WB, et al. Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein. Mol Cancer Ther. 2008;7(5):1044–1053.
  • Tugyi R, Uray K, Ivan D, et al. Partial D-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. P Natl Acad Sci USA. 2005;102(2):413–418.
  • Simon RJ, Kania RS, Zuckermann RN, et al. Peptoids - a modular approach to drug discovery. P Natl Acad Sci USA. 1992;89(20):9367–9371.
  • Cheng RP, Gellman SH, DeGrado WF Beta-peptides: from structure to function. Chem Rev. 2001;101(10):3219–3232.

• Paper about the synthesis of gamma-AApeptides

  • Niu YH, Hu YG, Li XL, et al. Gamma-AApeptides: design, synthesis and evaluation. New J Chem. 2011;35(3):542–545.
  • Niu YH, Padhee S, Wu HF, et al. Identification of gamma-AApeptides with potent and broad-spectrum antimicrobial activity. Chem Commun. 2011;47(44):12197–12199.

•• Paper relevant to the patent

•• The patent

  • Cai JF, Niu YH, Cai WB, et al. RGD mimetic gamma-AApeptides and methods of use. US Patent 20140004039 A1 2014.
  • Niu YH, Jones A, Wu HF, et al. Gamma-AApeptides bind to RNA by mimicking RNA-binding proteins. Org Biomol Chem. 2011;9(19):6604–6609.
  • Cai WB, Wu Y, Chen K, et al. In vitro and in vivo characterization of 64Cu-labeled Abegrin (TM) a humanized monoclonal antibody against integrin alpha(v)beta(3). Cancer Res. 2006;66(19):9673–9681.
  • Zhang Y, Hong H, Engle JW, et al. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging. 2012;2(1):1–13.
  • Hsu AR, Veeravagu A, Cai W, et al. Integrin alpha(v)beta(3) antagonists for anti-angiogenic cancer treatment. Recent Pat Anti-Canc. 2007;2(2):143–158.
  • Rosenthal MA, Davidson P, Rolland F, et al. Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases. Asia-Pac J Clin Onco. 2010;6(1):42–48.
  • Seo DW, Li HM, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114(2):171–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.